SAMIAIR

NeuroRx, Inc.

Application Filed: 2020-09-14
Trademark Application Details
Trademark Logo SAMIAIR

Mark For: SAMIAIR™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide. [all]

Status

2021-09-02 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Website www.neurorxpharma.com whois domain owner info
Research OneLook Acronym Finder
Serial Number90179858
Mark Literal ElementsSAMIAIR
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2021-02-23
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo

Timeline

2020-09-14Application Filed
2020-09-17Location: NEW APPLICATION PROCESSING
2020-09-17Status: Live/Pending
2020-09-17Transaction Date
2020-12-29Published
2021-02-23Location: INTENT TO USE SECTION
2021-08-16Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: NeuroRx, Inc.
Address1201 North Market Street, Suite 111 Wilmington, DELAWARE UNITED STATES 19801
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

NEURORX, INC.
913 NORTH MARKET STREET
WILMINGTON, DE 19801


Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-08-18
TEAS EXTENSION RECEIVED2021-08-16
EXTENSION 1 GRANTED2021-08-1698765
EXTENSION 1 FILED2021-08-1698765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2021-02-23
PUBLISHED FOR OPPOSITION2020-12-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-12-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-12-09
ASSIGNED TO EXAMINER2020-11-2188570
APPROVED FOR PUB - PRINCIPAL REGISTER2020-11-21
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-10-22
NEW APPLICATION ENTERED IN TRAM2020-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed